Injectable codeine is accessible for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may lead to nonimmune mast-mobile degranulation and resulting anaphylactoid reaction. Codeine suppositories are also marketed in some countries. In Ireland, new laws arrived into impact on 1 August 2010[ninety] concerning codeine, on account of https://codeingil.com/